(Q43991047)

28 November 2017

title

New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065. (English)

1 reference

28 November 2017

0 references

Feng Bai

1

1 reference

28 November 2017

Mark N Kirstein

series ordinal

2

1 reference

28 November 2017

Suzan K Hanna

series ordinal

3

1 reference

28 November 2017

Clinton F Stewart

series ordinal

4

1 reference

28 November 2017

publication date

1 June 2002

1 reference

Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences

28 November 2017

published in

1 reference

28 November 2017

volume

772

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

257-265

1 reference

describes a project that uses

28 November 2017

electrochemical detection

1 reference

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Can WR-2721 be improved upon?

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Pharmacokinetics of WR-2721.

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Protection of Normal Tissue from the Cytotoxic Effects of Chemotherapy and Radiation by Amifostine: Clinical Experiences

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Measurement of S-2-(3-Aminopropylamino)ethanethiol (WR1065) in Blood and Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

An improved HPLC assay for S-2-(3-aminopropylamino)ethyl phosphorothioate (WR-2721) in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Measurement of WR-2721, WR-1065, and WR-33278 in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Human pharmacokinetics of WR-2721

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Pharmacokinetics of amifostine and its metabolites in patients

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS1570-0232%2802%2900104-6

7 January 2021

10.1016/S1570-0232(02)00104-6

Identifiers

DOI

1 reference

28 November 2017

1 reference